Washington, D.C. (June 5, 2018) -- When Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, publicly listed pharmaceutical companies that have “potentially blocked access” to samples of their branded products to generic drug developers — thereby delaying competition — he won praise from many quarters....